Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130936
Status:
TERMINATED
Last Update Posted:
2016-02-15
First Post:
2005-08-15
Brief Title:
Study of Epirubicin Pharmorubicin Carboplatin Paraplatin and Capecitabine Xeloda ECC in the Treatment of Unresectable Locally Advanced or Metastatic GastricGastroesophageal Junction Cancer With Pharmacogenetic Correlates
Sponsor:
Organization:
AHS Cancer Control Alberta